Drseid
20.11.2021 - 05:06 PM
2
6
Pricing
7
Bottle
7
Sillage
8
Longevity
4.5
Scent

Can We Say "Norlimbanol?"...

Parvatha opens with very brief, slightly sharp bergamot citrus before quickly transitioning to its heart. As the composition enters its early heart, a somewhat sweet, faint green mint joins coniferous bracing pine before adding in supporting tart green apple, synthetic pineapple and piercingly sharp woody vetiver with hints of vague synthetic woods rising from the base. During the late dry-down the synthetic dry, vague woods take the fore in a dominant way, with only the tart apple and pineapple fruit from the heart hanging on in subtle support through the finish. Projection is very good and longevity very good to excellent at 11-12 hours on skin.

Parvatha is a perfume that shows some creativity early, only falling prey to a key ill that plagues so many other perfumes, the dreaded "vague synthetic woods" syndrome. At first, the perfumer combines a rather odd, but relatively interesting and effective mixture of tart fruit like green apple with synthetic smelling pineapple (while in no way going for anywhere near an Aventus dynamic) and sharp vetiver with green pine and natural mint of all things. The overall complex mixture is bizarre and not really pleasant smelling, but it does generally work for those that like that kind of oddball thing. If time stopped here, this review would probably be a neutral, as while I am not really a fan of the mix, I can't deny there is skill in putting so many unexpected ingredients and accords together. Alas, about halfway through the heart the wearer begins to notice vague synthetic dry woods (can we all say "norlimbanol?") that immediately become a negative distraction with a concrete-like aspect permeating the overall mixture, and by the late dry-down become the dominant and highly annoying player though the finish. I hate panning small up and coming indie brands, but alas a dud is a dud. The bottom line is the $130 per 50ml bottle extrait concentration Parvatha displays innovation early, only to whip out horrific norlimbanol in full-force late, yielding a "below average" 2 to 2.5 stars out of 5 rating and an avoid recommendation to all.
0 Comments